Cipher Pharmaceuticals (TSE:CPH) Stock Passes Below 50-Day Moving Average – What’s Next?

Cipher Pharmaceuticals Inc. (TSE:CPH) (NASDAQ:CPHR)’s share price passed below its 50 day moving average during trading on Monday . The stock has a 50 day moving average of C$12.26 and traded as low as C$11.03. Cipher Pharmaceuticals shares last traded at C$11.46, with a volume of 12,928 shares traded.

Analyst Ratings Changes

Separately, Canaccord Genuity Group set a C$12.50 price objective on Cipher Pharmaceuticals and gave the company a “hold” rating in a research note on Monday, April 7th.

Cipher Pharmaceuticals Trading Up 3.8 %

The stock has a market cap of C$205.74 million, a PE ratio of 12.66 and a beta of 1.20. The company has a quick ratio of 2.67, a current ratio of 2.00 and a debt-to-equity ratio of 41.22. The stock’s fifty day moving average price is C$12.26 and its 200 day moving average price is C$13.96.

Insider Activity

In other news, Director Harold Morton Wolkin sold 3,500 shares of the business’s stock in a transaction that occurred on Monday, March 24th. The shares were sold at an average price of C$13.49, for a total transaction of C$47,215.00. Corporate insiders own 42.00% of the company’s stock.

About Cipher Pharmaceuticals

Cipher Pharmaceuticals Inc is a specialty pharmaceutical company. Its products include Dermatology Products, Hospital Acute Care Products, and Out-Licensed Products among others. The company’s geographical segments include Canada and the United States.